Editing AUA: Female SUI (2023) (section)

==== UDS ====
* '''<span style="color:#ff0000">May be omitted for the index patient desiring treatment when SUI is clearly demonstrated'''
**'''<span style="color:#ff00ff">VALUE (NEJM 2012)</span>'''
***Population: 630 females with uncomplicated SUI
***Randomized to preoperative office evaluation and urodynamic tests vs. evaluation only
***Primary outcome: Treatment success at 12 months, defined as a reduction in the score on the Urogenital Distress Inventory of 70% or more and a response of “much better” or “very much better” on the Patient Global Impression of Improvement
***Results: preoperative office evaluation alone was not inferior to evaluation with urodynamic testing
***[https://pubmed.ncbi.nlm.nih.gov/22551104/ Nager, Charles W., et al. "A randomized trial of urodynamic testing before stress-incontinence surgery." ''New England Journal of Medicine'' 366.21 (2012): 1987-1997.]
* '''<span style="color:#ff0000">May be performed at the urologist’s discretion in certain non-index patients, including but not limited to (8):'''
*# '''<span style="color:#ff0000">Neurogenic lower urinary tract dysfunction</span>'''
*# '''<span style="color:#ff0000">Unconfirmed SUI</span>'''
*# '''<span style="color:#ff0000">Mismatch between subjective and objective measures</span>'''
*# '''<span style="color:#ff0000">Elevated PVR per clinician judgment</span>'''
*# '''<span style="color:#ff0000">Significant voiding dysfunction</span>'''
*# '''<span style="color:#ff0000">Significant urgency, UUI, overactive bladder (OAB)</span>'''
*# '''<span style="color:#ff0000">History of prior pelvic organ prolapse surgery</span>'''
*# '''<span style="color:#ff0000">History of prior anti-incontinence surgery</span>'''